GTG Signs Precision Medicine Pilot with Australia’s Largest Private Hospital Network
27 9월 2023 - 10:00PM
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”,
“GTG”) – a global leader in genomics-based tests in health,
wellness and serious disease is pleased to announce a partnership
with the Gold Coast Private Hospital (GCPH), a member of
Healthscope, to establish a Precision Medicine Clinic at the
hospital.
Highlights:
- Partnership will be initiated with a 50-patient pilot study to
establish workflow and patient reporting.
- Pilot study will utilise geneType Multi-risk test combined with
Pharmacogenomics (PGx) tests, providing a comprehensive wellness
profile for GCPH patients.
- Patient recruitment to commence immediately.
- Positive outcomes could enable the rollout of additional
Precision Medicine Clinics throughout the Healthscope network.
- Gold Coast Private Hospital by Healthscope is a 336 bed, 22
theatre hospital and home to leading doctors and surgeons from
around the world.
- Healthscope is Australia's only national private hospital
operation and healthcare provider with a network of 42 hospitals
that service every state and territory with 19,000 employees.
According to the US Food and Drug Administration
(FDA), Precision Medicine, also known as "personalised medicine" is
an innovative approach to tailoring disease prevention and
treatment that takes into account differences in people's genes,
environments, and lifestyles. The goal of precision medicine is to
target the right treatments to the right patients at the right
time. Utilising GTG’s geneType Multi-test and PGx tests will be an
important step in improving health outcomes for GCPH’s
patients.
Research Manager for the Gold Coast private
hospital, Michelle Ferrari Cestari, commented, “We have a clear
vision for a Precision Medicine Clinic that focuses on preventative
care, wellness and creating proactive patient pathways that lead to
early detection, and better treatment of the common diseases.”
-END-
Enquiries
Investor RelationsAdrian
MulcahyAutomic MarketsM: +61 438 630 411E:
adrian.mulcahy@automicgroup.com.au
About Genetic Technologies
Limited
Genetic Technologies Limited (ASX: GTG; Nasdaq:
GENE) is a diversified molecular diagnostics company. A global
leader in genomics-based tests in health, wellness and serious
disease through its geneType and EasyDNA brands. GTG offers cancer
predictive testing and assessment tools to help physicians to
improve health outcomes for people around the world. The company
has a proprietary risk stratification platform that has been
developed over the past decade and integrates clinical and genetic
risk to deliver actionable outcomes to physicians and individuals.
Leading the world in risk prediction in oncology, cardiovascular
and metabolic diseases, Genetic Technologies continues to develop
risk assessment products. For more information, please visit
www.genetype.com
About Gold Coast Private Hospital by
Healthscope
Gold Coast Private Hospital by Healthscope is a
336 bed and 22 theatre hospital is home to leading doctors and
surgeons. The focus is on the patient with and expert team of
surgeons, specialist doctors, dedicated nurses and other supporting
health professionals ensuring holistic health care experience is
the best it can be.
Offering the latest technology, and truly
impressive state-of-the-art facilities, they attract leading
doctors and surgeons from across the world. This, in turn, has
meant that we are the Gold Coast hospital of choice for GPs,
consultants and, of course, patients who quite rightly place a
premium on their health and wellbeing
https://goldcoastprivatehospital.com.au
Healthscope is Australia's only national private
hospital operation and healthcare provider with a network of 42
hospitals that service every state and territory. With over 19,000
people and provide work for nearly as many accredited medical
practitioners. Our people are known for achieving exceptional
clinical outcomes, transparent public reporting and positive
patient feedback that leads the industry. No matter the role, every
day the people make a difference to the lives of patients, their
families and carers, and it is a privilege to be part of their
care. https://healthscope.com.au/
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a4b69bd4-9db5-48df-8571-1c750c1c10c6
https://www.globenewswire.com/NewsRoom/AttachmentNg/49b7d9ad-c0a0-48c8-a599-e7fbec9517ce
Genetic Technologies (NASDAQ:GENE)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Genetic Technologies (NASDAQ:GENE)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025